Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non–muscle-invasive Bladder Cancer (BRIDGE)Max Kates, Michael A. Carducci, Xiangying Chu et al.|European Urology Focus|2023Cited by 49
Updates to Microhematuria: AUA/SUFU Guideline (2025)Daniel A. Barocas, Lesley Souter, Yair Lotan et al.|The Journal of Urology|2025Cited by 47
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not TherapeuticKelly K. Bree, Neema Navai, Andrea Kokorovic et al.|The Journal of Urology|2022Cited by 14
Revisiting an Old Conundrum: A Systematic Review and Meta-Analysis of Intravesical Therapy for Treatment of Urothelial Carcinoma of the ProstateAndrea Kokorovic, Neema Navai, Kate J. Krause et al.|Bladder Cancer|2021Cited by 10
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply.Kelly K. Bree, Neema Navai, Andrea Kokorovic et al.|The Journal of Urology|2023Cited by 0